Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hidemi Nakagawa is active.

Publication


Featured researches published by Hidemi Nakagawa.


Journal of Dermatological Science | 2001

Expression profiling of cancer-related genes in human keratinocytes following non-lethal ultraviolet B irradiation

Takashi Murakami; Mitsuo Fujimoto; Mamitaro Ohtsuki; Hidemi Nakagawa

Ultraviolet B irradiation initiates and promotes skin cancers, photo-aging, and immune suppression. In order to elucidate the effect of these processes at the level of gene expression, we used cDNA microarray technology to examine the effect of ultraviolet B irradiation on 588 cancer-related genes in human keratinocytes at 1, 6, and 24 h post-irradiation with a mildly cytotoxic dose of ultraviolet B (170 mJ/cm(2)). The viability of the irradiated keratinocytes was 75% at 24 h post-irradiation. Various cytokeratins and transcription factors were up-regulated within 1 h post-irradiation. After 6 h, expression of a variety of genes related to growth regulation (e.g. p21(WAF1), notch 4, and smoothened), apoptosis (e.g. caspase 10, hTRIP, and CRAF1), DNA repair (ERCC1, XRCC1), cytokines (e.g. IL-6, IL-13, TGF-beta, and endothelin 2), and cell adhesion (e.g. RhoE, and RhoGDI) were altered in human keratinocytes. These data suggest the changes in a cascade of gene expression in human keratinocytes occurring within 24 h after UVB exposure. Although the roles of these cellular genes after UVB-irradiation remain to be elucidated, microarray analysis may provide a new view of gene expression in epidermal keratinocytes following UVB exposure.


International Archives of Allergy and Immunology | 1994

Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid.

Akio Mori; Matsunobu Suko; Yoko Nishizaki; Osamu Kaminuma; G. Matsuzaki; Koji Ito; Takafumi Etoh; Hidemi Nakagawa; Nobuo Tsuruoka; Hirokazu Okudaira

Upon stimulation with phorbol ester and ionomycin, peripheral blood mononuclear cells (PBMC) of atopic patients with moderate eosinophilia produced significantly higher amounts of IL-5 compared to that of normal subjects. This finding renders further support to the notion that T cell-eosinophilic inflammation plays a central role in allergic disorders. IL-5 induction in vitro was completely inhibited by immunosuppressant FK506, cyclosporin A and dexamethasone. FK506 applied in vivo effectively suppressed clinical symptoms of atopic dermatitis and IL-5 production of PBMC. FK506 and cyclosporin A may become a better therapeutic modality against allergic diseases.


Archives of Dermatological Research | 1991

Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis

Hidemi Nakagawa; Shuichi Akazaki; Akihiko Asahina; Katsushi Tokunaga; Kazumasa Matsuki; Shoji Kuwata; Yasumasa Ishibashi; Takeo Juji

SummaryGenetic polymorphisms of HLA antigens and HLA-linked serum complement components (C2, C4A, C4B and BF) were investigated in 79 Japanese patients suffering from psoriasis. HLA typing revealed increased frequencies of HLA-A1, A2, B39, Bw46, Cw6, Cw7 and Cw11. Among complement components, positive associations were obtained with C4A4 and C4B2 and a negative association with BFF. The major histocompatibility complex haplotype (supratype), HLA-A2-Cw11-Bw46-C2C-BFS-C4A4-C4B2-DRw8 is purported to be a new high-risk haplotype in Japanese patients with psoriasis. Analysis of patients with this supratype via pulsed field gel electrophoresis showed the existence of specific, extensive DNA deletions near HLA-DR genes, but no disease-specific patterns could be observed by means of this technique. The newly-found high-risk haplotype indicates racial and ethnic differences among psoriatic patients.


British Journal of Dermatology | 1987

Naevus fusco‐caeruleus zygomaticus

Chee‐Ching Sun; Yau‐Chin Lü; Evelyn Fung Lee; Hidemi Nakagawa

One hundred and ten cases of an unusual type of naevus, which we have called naevus fusco‐caeruleus zygomaticus were studied. The naevus presents as a bilateral speckled discolouration of the skin of the face principally in the zygomatic region. The condition usually does not become apparent until the second decade of life, and is much commoner in females. No association with any other abnormalities was found.


British Journal of Dermatology | 1993

Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type.

I. Ando; Hyung-In Chi; Hidemi Nakagawa; Fujio Otsuka

Of 131 patients with non‐segmental vitiligo studied, 29 (22%) had a family history of this disorder. The clinical features and HLA antigens were assessed, and a comparison made between patients with familial and those with non‐familial, non‐segmental vitiligo. Familial patients developed skin lesions significantly earlier than non‐familial patients. There was a significant association between HLA‐B46 and familial non‐segmental vitiligo, whereas HLA‐A31 and CW4 were found in non‐familial patients.


Clinical Drug Investigation | 1996

Tacrolimus Has Antifungal Activities against Malassezia furfur Isolated from Healthy Adults and Patients with Atopic Dermatitis

Hidemi Nakagawa; Takafumi Etoh; Y. Yokota; F. Ikeda; K. Hatano; N. Teratani; K. Shimomura; Y. Mine; T. Amaya

SummaryTacrolimus (FK506), a new immunosuppressant used clinically in the prevention of allograft rejection, has been shown to be effective when used topically in atopic dermatitis, especially for face and neck lesions. Because Malassezia furfur, normally found in the seborrhoeic area, has been suggested to be one of the major allergens in atopic dermatitis and a provocative factor for face and neck lesions, the antifungal activity of tacrolimus against M. furfur was investigated. 26 strains of M. furfur were isolated from healthy adults and adult patients with atopic dermatitis. The growth of all the strains was inhibited by 0.5 to 32 mg/L of tacrolimus, whereas cyclosporin showed no such antifungal activity. This inhibition was found to be mediated by the fungicidal effects of tacrolimus. Microscopic examinations of M. furfur on the faces of patients with atopic dermatitis showed markedly diminished numbers of spores after 1 week’s treatment with topical tacrolimus ointment. The antifungal effects of tacrolimus against the causative allergenic yeast, M. furfur, may also be beneficial when treating face and neck atopic dermatitis with tacrolimus ointment.


Cancer Gene Therapy | 2001

Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model : successful treatment of oral melanoma and distant skin lesion

Jun Wang; Takashi Murakami; Yoji Hakamata; Takashi Ajiki; Yoshinori Jinbu; Yoko Akasaka; Mamitaro Ohtsuki; Hidemi Nakagawa; Eiji Kobayashi

Malignant melanoma involving the oral cavity has a highly metastatic potential. Curative surgery is required to resect extensive oral tissues and often results in dysfunction as well as a severe cosmetic deformity in patients with the disease. An alternative technology for the local and sustained delivery of cytokines for cancer immunotherapy has been shown to induce tumor regression, suppression of metastasis, and development of systemic antitumor immunity. However, local immunization of the oral cavity has not previously been studied. In this study, we examined the efficacy of particle-mediated oral gene transfer on luciferase and green fluorescent protein production. The results showed that these proteins were more significantly expressed in oral mucosa than the skin, stomach, liver, and muscle. Using an established oral melanoma model in hamsters, particle-mediated oral gene gun therapy with interleukin (IL) 12 cDNA was then conducted. The results indicated that direct bombardment of mouse IL-12 cDNA suppressed tumor formation and improved the survival rate. The skin tumor model created by inoculation of melanoma cells was also significantly inhibited by the oral bombardment of IL-12 cDNA coupled with an irradiated melanoma vaccine administrated to the oral mucosa, compared to treatment with a percutaneous vaccine. IL-12 gene gun therapy, combined with an oral mucosal vaccine, induced interferon-γ mRNA expression in the host spleen for a long time. These results suggest that immunization of oral mucosa may induce systemic antitumor immunity more efficiently than immunization of the skin and that oral mucosa may be one of the most suitable tissues for cancer gene therapy by means of particle-mediated gene transfer. Cancer Gene Therapy (2001) 8, 705–712


The Journal of Allergy and Clinical Immunology | 1994

Polymorphisms of transporter associated with antigen processing genes in atopic dermatitis

Shoji Kuwata; Masami Yanagisawa; Hidehisa Saeki; Hidemi Nakagawa; Takafumi Etoh; Katsushi Tokunaga; Takeo Juji; Yoichi Shibata

We investigated polymorphisms of transporter associated with antigen process (TAP) genes in atopic dermatitis. We developed a polymerase chain reaction-restriction fragment length polymorphism method for discriminating TAP alleles. Genomic DNA was obtained from 29 Japanese patients with atopic dermatitis and 35 control subjects. Dimorphic regions of TAP1 and TAP2 genes were amplified by polymerase chain reaction. Amplified products were digested with restriction endonucleases to determine TAP alleles: Sau3A1 for TAP1 codon 333 (Ile-Val), AccI for TAP1 codon 637 (Asp-Gly), and EcoRII for TAP2 codon 687 (Gln-Stop). We observed four alleles for TAP1 and dimorphism for TAP2 codon 687. Six of 35 controls had the TAP1 D allele, which has been reported to be a rare allele in Caucasian populations. Gene frequency of TAP1 637Asp exhibited a tendency to increase in the patients with atopic dermatitis. TAP1 637Asp and TAP1 A alleles were estimated to constitute a haplotype with DRB1* 1302-DQB1*0604 and DRB1*0803-DQB1*0601 in the Japanese population. Because TAP1 and TAP2 genes are located between HLA-DQB1 and -DPB1 loci, analysis of TAP gene polymorphisms will be useful for a better understanding of susceptibility loci in HLA class II-associated disease.


Journal of Dermatology | 1997

Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses.

Ken Iozumi; Hidemi Nakagawa; Kunihiko Tamaki

We describe a case of elastosis perforans serpiginosa with additional findings of degenerative skin changes. A 20‐year‐old man with hepatolenticular degeneration, under prolonged treatment with D‐penicillamine, presented with a circular or serpiginous arrangement of nuchal papules. Histopathologically, transepidermal channels were accompanied by granulomatous reactions, with several giant cells engulfing elastic fibers. In addition to these findings of a typical elastosis perforans serpiginosa, we observed scar‐like skin changes inside the circular arrangement of the papules. At the scar‐like tissue, we found electron‐microscopical evidence of randomly aggregated thin collagen fibers with no tendency toward systemic combined bundle formation, which is a characteristic feature of normal collagen fiber formation. Pseudoxanthoma‐elasticum‐like changes were observed on his neck. On his axillae and groin, slight skin thickening and wrinkling were detected. The diagnosis of elastosis perforans serpiginosa does not represent all of the manifestations or the pathological background described above. The skin manifestations described here represent not only an elastosis but also a total degenerative dermatosis with over‐healed collagenosis. Thus, those dermatoses should be summarized as one entity, penicillamine‐induced degenerative dermatosis. After considering the pathogenic background and clinical similarities, we further propose to simplify the penicillamine‐induced skin manifestations to three categories: acute sensitivity reactions, bullous dermatoses, and degenerative dermatoses.


Journal of The American Academy of Dermatology | 1992

Systemic elastolytic granulomatosis with cutaneous, ocular, lymph nodal, and intestinal involvement: Spectrum of annular elastolytic giant cell granuloma and sarcoidosis

Nobuyuki Kurose; Hidemi Nakagawa; Ken Iozumi; Toshitatu Nogita; Masutaka Furue; Yasumasa Ishibashi

A 15-year-old Japanese girl had widespread annular serpiginous erythematous plaques, bilateral granulomatous uveitis, bloody diarrhea, and seronegative arthralgia. She also had anemia and leukopenia. The histopathologic findings were compatible with those of annular elastolytic giant cell granuloma. Elastolytic granulomas were also found in the cervical lymph nodes, terminal ileum, parietal peritoneum, and mesentery. Bilateral hilar lymphadenopathy, hypercalcemia, and an increased level of angiotensin converting enzyme were not observed throughout the clinical course. To the best of our knowledge, systemic elastolytic granulomatosis has not been previously described in annular elastolytic giant cell granuloma or sarcoidosis. This case may represent a type of granulomatosis in the broad spectrum of annular elastolytic giant cell granuloma and sarcoidosis.

Collaboration


Dive into the Hidemi Nakagawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge